Author Correction: Experimental study on thioredoxin redox inhibitor 1-methylpropyl 2-imidazolyl disulfide promoting apoptosis of multiple myeloma cells in vitro and in vivo.
Eur Rev Med Pharmacol Sci
; 27(1): 2, 2023 Jan.
Article
em En
| MEDLINE
| ID: mdl-36647846
ABSTRACT
Correction to European Review for Medical and Pharmacological Sciences 2022; 26 (4) 1283-1292. DOI 10.26355/eurrev_202202_28121-PMID 35253185-published online on December 15, 2022. After publication, the authors corrected the order of the author's affiliations as follows Q.-D. Lin1,2,3,4, L.-N. Liu1,2,3,4, X.-Y. Liu1,2, Y. Yan1,2, B.-J. Fang1,2,3,4, Y.-L. Zhang1,2,3,4, J. Zhou1,2,3,4, Y.-F. Li1,2,3,4, W.-L. Zuo1,2,3,4, Y.-P. Song1,2,3,4 1Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou City, Henan Province, China 2Henan Cancer Hospital, Zhengzhou City, Henan Province, China 3Henan Key Lab of Experimental Hematology, Zhengzhou City, Henan Province, China 4Henan Institute of Hematology, Zhengzhou City, Henan Province, China There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause. https//www.europeanreview.org/article/28121.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Eur Rev Med Pharmacol Sci
Ano de publicação:
2023
Tipo de documento:
Article